Merck & Co reported a quarterly loss compared with a year-ago profit on Friday, hurt by a charge related to the formation of a collaboration with AstraZeneca Plc.
Net loss attributable to Merck was $56 million, or 2 cents per share, for the third quarter, compared with a year-ago profit of $2.18 billion, or 78 cents per share.
Sales fell to $10.33 billion from $10.54 billion.
(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.